A study of AVXS 101 in patients with spinal muscular atrophy type 1, 2, 3.
Phase of Trial: Phase III
Latest Information Update: 18 Jan 2018
At a glance
- Drugs AVXS 101 (Primary)
- Indications Spinal muscular atrophy
- Focus Therapeutic Use
- Acronyms REACH
- 18 Jan 2018 New trial record
- 16 Jan 2018 According to a AveXis media release, this trial may expect to start in late Q4 2018 or early 2019.